In vivo and In vitro properties evaluation of curcumin loaded MgO doped 3D printed TCP scaffolds

The lack of site-specific chemotherapeutic agents to treat bone malignancy throws a significant challenge in the design of a delivery vehicle. The major scientific question posed in this study is, can we utilize curcumin-loaded magnesium oxide (MgO) doped 3D printed tricalcium phosphate (TCP) bone grafts as a localized delivery system that improves early stage in vivo osseointegration and in vitro chemoprevention, antibacterial properties? We have utilized curcumin as an alternative natural chemopreventive agent for bone cancer-specific delivery after direct incorporation on the 3D printed tricalcium phosphate (TCP) bone grafts. The addition of MgO as a dopant to TCP leads to similar to 1.3 times enhancement in compressive strength. The designed drug delivery system shows up to similar to 22% curcumin release in a physiological pH of 7.4 after 30 days. The presence of curcumin leads to up to similar to 8.5 times reduction in osteosarcoma viability. In vitro results indicate that these scaffolds significantly enhance bone-forming osteoblast cells while reducing the bone-resorbing osteoclast cells. The in vivo rat distal femur model surgery followed by histological assessment with H&E, vWF, and Movat pentachrome staining results show that the designed scaffolds lead to new bone formation (up to similar to 2.5 times higher than the control) after successful implantation. The presence of MgO and curcumin results in up to similar to 71% antibacterial efficacy against osteomyelitis causing S. aureus. These 3D printed osteogenic and chemopreventive scaffolds can be utilized in patient-specific low load-bearing defect sites.

Automated summary

The study aims to design a localized delivery system using curcumin-loaded magnesium oxide (MgO) doped 3D printed tricalcium phosphate (TCP) bone grafts for improved early stage osseointegration, chemoprevention, and antibacterial properties. The drug delivery system showed about 22% curcumin release after 30 days and resulted in approximately 8.5 times reduction in osteosarcoma viability. In vivo experiments demonstrated new bone formation up to 2.5 times higher than the control group, and the presence of MgO and curcumin exhibited about 71% antibacterial efficacy against S. aureus-induced osteomyelitis. These 3D printed osteogenic and chemopreventive scaffolds are suitable for patient-specific low load-bearing defect sites.